For research teamsHelp me find a study
Back to all studies
CompletedNCT01765127

An Observational Modified Prescription-event Monitoring Study of Asenapine (Sycrest)

This study is completed. It focuses on bipolarity and currently lists study information in the United Kingdom.

BipolarityOther
Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT01765127. We help you review the study, but cannot decide medical eligibility.
In plain English

Key information made simple

What is this study testing?

This observational study follows people living with bipolarity to understand their experience, outcomes, or changes over time.

What would participation involve?

Participants may answer questionnaires, join interviews, or provide follow-up information, complete questionnaires or follow-up assessments, attend study visits with the research team. The registry lists locations in United Kingdom.

Who is it mainly for?

This study appears to be mainly for people with bipolarity.

What should you check before joining?

Ask about whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

What to expect

Your next step

The official record suggests in-person participation through a clinic, with sites including Drug Safety Research Unit (for data collation and analysis only) in Southampton. Participation appears to center on questionnaires, assessments, or follow-up information rather than a study treatment. The main fit is usually meeting the main study requirements, while common reasons not to take part include active substance or alcohol problems that could affect the results and other factors that could make participation unsuitable. The official record does not list a trial phase, which usually means the study is focused on observation rather than testing a staged treatment.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateJanuary 2012
Recruitment status
Completed
Estimated enrollment
Not clearly listed
Sponsor
Professor Saad Shakir
Sponsor type
Individual investigator
Study type
Other
Intervention type
Other / unclear
Study phase
Not clearly listed
Locations
United Kingdom
Age range
Not clearly listed
Official registry ID
NCT01765127
Official title
An Observational Modified Prescription-event Monitoring Study of Asenapine (Sycrest)
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT01765127. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Taking part may help improve understanding of your condition.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in United Kingdom.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring observational follow-up for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Why is the study type not clearly categorized?

The study type is not clearly categorized in the public registry. Focus on the objective, required tasks, visits, any intervention, and eligibility criteria, then ask the study team to confirm.

Do I need to want to stop or reduce tobacco use to participate?

The public registry appears to mention tobacco, nicotine, alcohol, cannabis, or another addiction-related topic. Ask the study team whether you need to want to stop, reduce, already be abstinent, or simply meet use-related criteria. Eligibility must be confirmed by the study team.

What would I likely need to do?

The public registry does not clearly describe all participation steps. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What risks or points should I check?

The public registry does not make the main risk category clear. Ask the study team what activities are required, what could feel uncomfortable, how safety is monitored, and what happens if you want to stop. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Professor Saad Shakir, which appears to be an individual investigator. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The registry indicates that this study is completed. It may still be useful for understanding the research, but you are unlikely to be able to join.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.